OB/GYN Clinical Alert – January 1, 2012
January 1, 2012
View Issues
-
Posterior Tibial Nerve Stimulation Works for Overactive Bladder
In a retrospective chart review at a single university urogynecology practice between 2000 and 2009, the authors identified 197 patients who underwent posterior tibial nerve stimulation (PTNS) after failing medical therapy for overactive bladder (OAB) with anticholinergic medication. -
IUDs and Cervical Cancer Risk
The investigators performed a pooled analysis of individual data from two large studies by the International Agency for Research on Cancer (IARC) and Institut Català d'Oncologia (ICO) research program on human papillomavirus (HPV) and cervical cancer. -
Cytomegalovirus in Pregnancy
Dealing with cytomegalovirus (CMV) can be vexing for everybody involved, but a recent paper may help with the management and counseling of patients infected with this virus at different times before and during pregnancy. Feldman et al studied 580 pregnant patients who were diagnosed with seriologic evidence of CMV infection. -
Risk of Vaginal Cuff Dehiscence in Minimally Invasive Hysterectomy
In the initial phase of data collection, the authors identified two vaginal cuff dehiscences out of 665 total laparoscopic hysterectomies with transvaginal cuff closure (0.3%). -
Hot Flash Treatment: 2011
Hot flashes occur as a common consequence of breast cancer therapy and are quite debilitating for some. -
Special Feature: Deciphering the Clues that Make Cancer...'Cancer'
The Cancer Genome Atlas research network (TCGA) is an open-sourced multi-institutional collaborative charged by the National Cancer Institute (NCI) and the National Human Genome Research Institute effort to explore the molecular aberrations of cancer to better understand the disease and identify new treatment approaches. -
Pharmacology Watch: Rivaroxaban Now Approved for Stroke Prevention
In this issue: New indication for rivaroxaban; new study on warfarin testing; medications causing adverse drug events; niacin as an add-on therapy; and FDA actions. -
Clinical Briefs in Primary Care supplement